Medicament for treating diabetic foot

A technology for diabetic foot and drug, applied in drug combination, metabolic diseases, skin diseases, etc., can solve the problems of slow effect and insignificant treatment effect, and achieve the effect of good curative effect and quick effect.

Inactive Publication Date: 2014-02-12
TIANJIN PACIFIC PHARMA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to overcome the shortcomings of inconspicuous therapeutic effect and slow effect, and provide a medicine for treating diabetic foot

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for treating diabetic foot
  • Medicament for treating diabetic foot
  • Medicament for treating diabetic foot

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A medicine for treating diabetic foot, comprising: Angelica sinensis, Salvia miltiorrhiza, Ganoderma lucidum, Panax notoginseng, Purslane, Saponaria japonica, Alisma alisma, wherein the ratio of parts by weight of each component is:

[0016]

Embodiment 2

[0018] A medicine for treating diabetic foot, comprising: Angelica sinensis, Salvia miltiorrhiza, Ganoderma lucidum, Panax notoginseng, Purslane, Saponaria japonica, Alisma alisma, wherein the ratio of parts by weight of each component is:

[0019]

[0020]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a medicament for treating diabetic foot. The medicament comprises the following components in parts by weight: 10-18 parts of angelica, 6-12 parts of red sage root, 6-15 parts of ganoderma lucidum, 3-8 parts of notoginseng, 5-8 parts of purslane, 2-6 parts of spina gleditsiae and 8-18 parts of rhizoma alismatis. The medicament provided by the invention has the advantages and positive effects of good curative effect, high effect taking speed and capability of avoiding worries of a patient about amputation in a later period.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating diabetic foot. Background technique [0002] Diabetic foot is one of the common complications of diabetes, which is caused by diabetic macrovascular disease and neuropathy. Treatment is very difficult, and it is a treatment "difficulty" that has not yet been overcome in China. There are some obvious deficiencies in the western medicine and traditional Chinese medicine currently used to treat diabetic foot: one is that the effect is not obvious enough, and the other is that the effect is relatively slow. "Surgery, resulting in disability. Contents of the invention [0003] The purpose of the invention is to overcome the shortcomings of inconspicuous therapeutic effect and slow effect, and provide a medicine for treating diabetic foot. [0004] Technical scheme of the present invention is: [0005] A medicine for treating diabetic foot, comprising: Ang...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/884A61P3/10A61P9/14A61P17/02
Inventor 宋德成郎琳高永清邸克来王磊
Owner TIANJIN PACIFIC PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products